GW406381X

Known as: GW406381 
 

Topic mentions per year

Topic mentions per year

2004-2016
01220042016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
An exposure-response model was used to characterize the pharmacokinetic-pharmacodynamic relationship of GW406381, a COX-2… (More)
Is this relevant?
2009
2009
OBJECTIVES To evaluate the efficacy and tolerability of 4 doses of GW406381, a cyclooxygenase-2 inhibitor, compared with placebo… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2009
2009
UNLABELLED In this randomized, double-blind, placebo-controlled study, we evaluated the efficacy and safety of GW406381, an… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2008
2008
The objective of the present study was to explore the clinical efficacy and tolerability of GW406381, a cyclooxygenase-2 (COX-2… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
2008
2008
CONTEXT GW406381 is an investigational, highly selective cyclooxygenase-2 (COX-2) inhibitor that is effective in animal models of… (More)
Is this relevant?
2007
2007
There are several lines of evidence to suggest that cyclooxygenase-2 (COX-2) plays an important role in the generation and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
The pathogenic form of the cyclooxygenase (COX) enzyme, COX-2, is also constitutively present in the spinal cord and has been… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2004
2004
GW406381 (8), currently undergoing clinical evaluation for the treatment of inflammatory pain is a member of a novel series of 2… (More)
Is this relevant?